Work

A Phase 2b Study of Fovista™, a Platelet Derived Growth Factor (PDGF) inhibitor in combination with a Vascular Endothelial Growth Factor (VEGF) inhibitor for Neovascular Age-Related Macular Degeneration (AMD)

Year: 2013

Type: article

Source: Investigative Ophthalmology & Visual Science

Author: David S. Boyer

Institution: Retina Vitreous Associates Medical Group

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1912379587

FWCI: 4.056

Cites:

Cited by: 14

Related to: 10